Piramal Pharma informs about disclosure

27 Apr 2024 Evaluate

Pursuant to Regulation 30 of the SEBI Listing Regulations, Piramal Pharma has informed that the Company has received on 26th April 2024 assessment orders from the Office of The Navi Mumbai Municipal Corporation, Cess Department (‘Orders’), levying penalty aggregating to Rs 3,500 under the Bombay Provincial Municipal Corporation (Cess on Entry of Goods) Rules, 1996. The Orders were passed in connection with the disclosure requirement of cess liability in returns for the pre-acquisition period 1st April, 2008 to 31st March, 2011 and 1st April, 2012 to 31st March, 2013 in the matter of Hemmo Pharmaceuticals, which amalgamated with the Company in August, 2022. The said Orders does not have any material impact on financials, operation or other activities of the Company.

The above information is a part of company’s filings submitted to BSE.

Piramal Pharma Share Price

222.00 -8.05 (-3.50%)
04-Apr-2025 09:52 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1709.40
Dr. Reddys Lab 1109.75
Cipla 1415.55
Lupin 1971.10
Zydus Lifesciences 866.65
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...